- Q1 2024 AIM ImmunoTech Inc Earnings Call TranscriptMay 16, 2024$0.39 (-2.40%)Earnings
- Q4 2023 AIM ImmunoTech Inc Earnings Call TranscriptApr 02, 2024$0.45 (-8.18%)Earnings
- AIM ImmunoTech Inc at HC Wainwright Investment Conference - New York TranscriptSep 11, 2023
- Q2 2023 AIM ImmunoTech Inc Earnings Call TranscriptAug 15, 2023$0.6425 (-6.34%)Earnings
- AIM ImmunoTech Inc Investor Summer Spotlight Series TranscriptJul 12, 2023
- Q1 2023 AIM ImmunoTech Inc Earnings Call TranscriptMay 16, 2023$0.42495 (-0.01%)Earnings
- Q4 2022 AIM ImmunoTech Inc Earnings Call TranscriptApr 03, 2023$0.42 (-2.33%)Earnings
- AIM ImmunoTech Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- AIM ImmunoTech Inc at JTC Team Top Picks Virtual Investor Conference TranscriptJan 26, 2022
- AIM ImmunoTech Inc at SNN Network Virtual Conference TranscriptAug 03, 2020
- AIM ImmunoTech on Commercial Launch in Argentina for Chronic Fatigue and COVID-19 Clinical Trials- Corporate Analyst Meeting TranscriptJul 31, 2020
- CEO Roadshow Interview: Thomas Equels, CEO of AIM Immunotech Corporate Analyst Meeting TranscriptJun 24, 2020
- AIM ImmunoTech greenlit to import chronic fatigue syndrome drug into Argentina Corporate Analyst Meeting TranscriptJun 22, 2020
- AIM ImmunoTech Inc To Describe Their Approach and Progress with Ampligen to Combat COVID-19 TranscriptMay 28, 2020
- AIM ImmunoTech Inc at SNN Planet MicroCap Showcase TranscriptApr 22, 2020
Q1 2023 AIM ImmunoTech Inc Earnings Call Transcript
Hello, and welcome to the AIM ImmunoTech quarterly update conference call and webcast. (Operator Instructions) Note that this webcast is being recorded at the company's request and a replay will be made available on the company's website following the end of the event.
At this time, I'd like to remind our listeners that remarks made during this webcast may state management's intentions, beliefs, expectations, or future projections. These are forward-looking statements and involve risks and uncertainties. Forward-looking statements on this call are made pursuant to the Safe Harbor provisions of the federal securities laws and are based on AIM's current expectations and actual results could differ materially. As a result, you should not place undue reliance on any forward-looking statements.
Some of the factors that could cause actual results to differ materially from these contemplated by such forward-looking statements are discussed in the periodic reports AIM filed with the Securities and Exchange Commission. These documents are available on the Investors section of the company's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)